This review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma
risk, diagnostics, treatment and outcomes, while identifying gaps that aim to stimulate further …

Pancreatic cancer arises from noninvasive precursor lesions, including pancreatic
intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), and …

Studies using cell lines should always characterize these cells to ensure that the results are
not distorted by unexpected morphological or genetic changes possibly due to culture time …

Pancreatic adenocarcinoma (PAAD) is a common, highly malignant, and aggressive
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …

Background and Aims The value of next-generation sequencing (NGS) of pancreatic cyst
fluid relative to the clinical and imaging impression has not been well-studied. The aim of …

BACKGROUND The diagnosis of a pancreatic cyst as mucinous or high‐risk dictates the
need for follow‐up or surgery. Molecular analysis of aspirated pancreatic cyst fluid (PCF) …

Background The prevalence and clinical significances of KRAS, GNAS, and RNF43
mutations in patients with pancreatic intraductal papillary mucinous neoplasm (IPMN) …

There are three types of pancreatic neoplasms that predominantly have an intraductal
growth pattern: the common, usually cystic, intraductal papillary mucinous neoplasms …

Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer death.
Although the treatment modalities are improving, the prognosis of PDAC continues to be …

Morphological heterogeneity is a common finding in pancreatic ductal adenocarcinoma.
Inter-and intra-tumour heterogeneity relates not only to the microscopic appearances of the …